Sphere Medical's Proxima 3 device showed comparable performance to lab-based and point-of-care blood gas analyzers used in a clinical environment, according to a U.K. study of 105 blood samples from 18 surgical patients. The company is gearing up to obtain CE mark approval for the device, which could be released in the U.K. in the first half of next year, CEO Stuart Hendry said.
Sphere Medical eyes 2014 release of Proxima 3 device in U.K.
SmartBrief Job Listings for Health Care
|Chief Executive Officer||
CarePoint Health Plan
|Jersey City, NJ|
|Regional Director, Southeastern Region - State Affairs||
America's Heatlh Insurance Plans (AHIP)
|Assistant General Counsel||
|Pharmacy Care Manager||
National Association of Chain Drug Stores
|Senior Director, Research||
America's Health Insurance Plans (AHIP)